In current study Homocysteine (Hcy) plasma levels has been evaluated in patients with coronary artery disease but without any other well-known risk factor for heart disease, in comparison with an healthy control group. The achieved results have shown a statistically significant tHcy plasma levels increasing, establishing the pathogenetic role of this sulphorate amino acid toward atherosclerotic course.